Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +2.79% |
|
+0.30% | -35.41% |
06-11 | Transcript : Vistagen Therapeutics, Inc., Q4 2024 Earnings Call, Jun 11, 2024 | |
06-11 | Vistagen Therapeutics, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.41% | 87.29M | |
+16.45% | 123B | |
+21.96% | 115B | |
+23.73% | 25.85B | |
-20.05% | 20.9B | |
-16.28% | 16.77B | |
-16.52% | 16.52B | |
-44.35% | 15.56B | |
+63.91% | 15.49B | |
+2.52% | 13.45B |
- Stock Market
- Equities
- VTGN Stock
- News Vistagen Therapeutics, Inc.
- Transcript : Vistagen Therapeutics, Inc., Q2 2024 Earnings Call, Nov 09, 2023